Research programme: anti-alpha folate receptor monoclonal antibody - Dompe

Drug Profile

Research programme: anti-alpha folate receptor monoclonal antibody - Dompe

Alternative Names: AFRA; Anti-α-FR Mab; FabOvar

Latest Information Update: 29 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dompe Farmaceutici
  • Developer Advanced Accelerator Applications; Dompe Farmaceutici
  • Class Monoclonal antibodies
  • Mechanism of Action Folate receptor 1 antagonists; Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Ovarian cancer

Most Recent Events

  • 29 Jun 2016 Discontinued - Preclinical for Ovarian cancer in Italy (Parenteral)
  • 01 Aug 2011 FabOvar licensed to Advanced Accelerator Applications
  • 01 Aug 2011 Preclinical trials in Ovarian cancer in Italy (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top